A biotech firm based in Boulder, CO is providing free access to MAD7 a novel enzyme in the gene editing field.
Biotech Start-Up Democratizes CRISPR with Free-Access to Enzyme
Biotech Start-Up Democratizes CRISPR with Free-Access to EnzymeA biotech firm based in Boulder, CO is providing free access to MAD7 a novel enzyme in the gene editing field.
20% of Young Colon Cancer Patients Have Inherited Genetic Abnormality
20% of Young Colon Cancer Patients Have Inherited Genetic AbnormalityA new study indicates a benefit for all young colon cancer patients to have genetic testing.
Light-Up Specks Find and Track Tiny Tumours
Light-Up Specks Find and Track Tiny TumoursScientists have created a method to detect tiny tumors and track their spread using light-emitting nanoparticles.
Thermo Fisher Scientific Launches New Research Assay for Cancer
Thermo Fisher Scientific Launches New Research Assay for CancerThermo Fisher Scientific has launched a new targeted next-generation sequencing research panel for the analysis of cancer-relevant genes.
Sanofi is One Step Closer to Challenging Blockbuster Diabetes Sales from its Rival
Sanofi is One Step Closer to Challenging Blockbuster Diabetes Sales from its RivalSanofi's Admelog is the first meal-time insulin copy the FDA has approved.
A new study indicates a benefit for all young colon cancer patients to have genetic testing.
Scientists have created a method to detect tiny tumors and track their spread using light-emitting nanoparticles.
Thermo Fisher Scientific has launched a new targeted next-generation sequencing research panel for the analysis of cancer-relevant genes.
Sanofi’s Admelog is the first meal-time insulin copy the FDA has approved.
The largest organisation of scientists who work in gene and cell therapy have come out against DIY gene therapies.
Webinars & Media
A discussion of the technology that is in use today that allows Metabolon to carry out n of 1 studies that enable precision medicine, as well as future technology. Available on-demand.
Looking at applications for the MinION in new molecular approaches for the taxonomy characterization of microbial communities aiming resolution at species and strain level. Available on-demand.
Overcoming challenges of transferring large data to and from the Cloud, while achieving maximum data transfer efficiency, reliability, and security. Available on-demand.
The Short Read
We’ve caught up with Mike before his participation in the panel: ‘Can we fully integrate genomics into the NHS within 5 years?’ at the Festival of Genomics 2018.
“Ensuring All Stakeholders Understand the Value of Genomics Can Be a Challenge” – Catalina Lopez-Correa
We’ve caught up with GenomeBC’s CSO, Dr. Catalina Lopez-Correa ahead of Festival of Genomics in London, January 2018.
“We Need to be Able to Handle Large Scale Datasets to Prepare for This ‘Big Data’ Era” – Mark Gerstein
Mark Gerstein, PhD, gives us some inside information on applying computational approaches to problems in molecular biology.
Magazines and Educational Guides
In this issue of the magazine we tackle infectious disease, whilst taking a look at what AMP 2017 has on offer this year in Salt Lake City, Utah.
In this issue of the magazine we head to Orlando, Florida, for the largest genetics meeting in the world: welcome to ASHG 2017.
This free guide will introduce you to some of the most important features for genomicists in the cloud.
Just as sequencing has been getting faster, so too has library preparation. The process can be broadly broken up into 5-6 main stages, depending on method.
Technology has come a long way in the last four decades. Dr. Tonellato has been able to watch how it has changed computational genomics for the better.
Does genomics have the power to revolutionise infectious disease control? We have brought together a panel of experts to answer just that.
We’ve caught up with Haim Neerman, CEO of Variantyx, to find out why the clinic is making the move to whole genome sequencing.
With the Festival of Genomics London just around the corner, we thought it was the right time to turn our attention to the key themes being presented.
The Mayo Clinic’s David Smith discusses how Hollywood under-utilize, or so horribly mangle, good science fiction material.
Around the Web
A new hyperlens crystal is capable of resolving details as small as a virus on the surface of living cells.
Researchers from the University of Michigan have identified a vicious cycle of toxic protein production set in motion by cell stress that contributes to ALS
DNA sequences between mitochondria within a single cell are vastly different, researchers have found.
Warming up for the weekend, we have a review of gene therapy, the lab of the future, and schools paving the way for big data analytics.
The most studied genes of all time; iPhone ultrasounds; migration of top life science talent; and still no science advisor at the White House…
Artifical embryos, databases offering clues on who likes beer, self-destruct switches in mosquitos and infectious disease…